European Companies Search Engine
State Aid (€9,169,000): Flemish Resilience / RRF, Project VV021-13 'AAV Gene Therapy' (KU Leuven) Sat5 Nov 2021 State Aid Transparency (Direct grant/ Interest rate subsidy)
Overview
Text
| Country | Belgium |
| Language | Dutch |
| Aid Measure Title | Vlaamse Veerkracht / RRF, Project VV021-13 'AAV Gentherapie' (KU Leuven) (en: Flemish Resilience/RRF, Project VV021-13 “AAV Gentherapy” (KU Leuven)) |
| SA.Number | SA.101703 |
| Ref-no. | TM-10944446 |
| National ID | 0419.052.173 |
| Beneficiary National ID Type | KBO/BCE |
| Name of the beneficiary | KU Leuven |
| Beneficiary Type | Only large enterprises |
| Region | VLAAMS GEWEST |
| Sector (NACE) | Other research and experimental development on natural sciences and engineering |
| Aid Instrument | Direct grant/ Interest rate subsidy |
| Objectives of the Aid | Fundamental research (Art. 25(2)(a)) |
| Date of Granting | 05/11/2021 |
| Aid element, expressed as full amount | 9,169,000.00 EUR |
| Granting Authority Name | EWI |
| Co-finance | ✓ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Katholieke Universiteit te Leuven, Leuven, Belgium.